Skip to main content
Equibles

GABELLI FUNDS LLC

Position in NEO — Neogenomics Inc

CIK 1081407 Rye, NY
Back to NEO Full portfolio

Position in NEO

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$1,597,605
+$785,115 QoQ
Shares Held
109,500
0.0% QoQ
Ownership
0.085%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#75
of 266 holders
Holding Since
Mar 2020
21 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NEO Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

GABELLI FUNDS LLC holds $33,829,409 across 15 Diagnostics & Research names. NEO ranks #8 (4.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TMO
Thermo Fisher Scientific Inc.
 16,090 $8,066,882
2 LH
Labcorp Holdings Inc.
 27,447 $7,685,160
3 MTD
Mettler Toledo International Inc/
 2,500 $3,193,775
4 DHR
Danaher Corp /De/
 16,250 $3,095,300
5 WAT
Waters Corp /De/
 7,877 $2,954,190
6 GRAL
GRAIL, Inc.
 30,283 $2,067,420
7 A
Agilent Technologies, Inc.
 13,309 $1,767,834
8 NEO
Neogenomics Inc
This page 		109,500 $1,597,605

All Filings in NEO

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,597,605 109,500
2026-03-31 $812,490 109,500
2025-12-31 $1,399,440 119,000
2025-09-30 $918,680 119,000
2025-06-30 $869,890 119,000
2025-03-31 $939,510 99,000
2024-12-31 $230,720 14,000
2024-09-30 $265,500 18,000
2024-06-30 $249,660 18,000
2024-03-31 $282,960 18,000
2022-09-30 $241,080 28,000
2022-06-30 $391,200 48,000
2022-03-31 $591,705 48,700
2021-12-31 $1,525,164 44,700
2021-09-30 $2,156,328 44,700
2021-06-30 $2,064,269 45,700
2021-03-31 $2,179,996 45,200
2020-12-31 $3,217,478 59,760
2020-09-30 $2,423,673 65,700
2020-06-30 $2,741,730 88,500
2020-03-31 $1,656,600 60,000